Cogent Biosciences filed an offering with the SEC, with Leerink partners as the joint book-running manager and Broadridge handling prospectus info.
3 reports, 1 independent
Updated Jul 11
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cogent Biosciences filed an offering with the SEC, with Leerink partners as the joint book-running manager and Broadridge handling prospectus info.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cogent Biosciences (United States)
company in Waltham, United States
Nothing else this week.
-
Leerink partners
U.S. investment bank
-
Broadridge Financial Solutions
American corporate services company
Related events
- Kazia Therapeutics Limited is seeking joint bookrunning management and co-management for a proposed offering, with Leerink partners and Needham & Company involved.
- Broadridge Financial Solutions and Mastech Digital are two industrial companies that are currently being compared.
- TD Cowen is managing a share offering for PMV Pharma, which has been filed with the SEC and utilizes Broadridge Financial Solutions for mailing the prospectus.
Coverage
Newest first; wire copies grouped- GlobeNewswireCogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares WALTHAM, Mass. and BOULDER, Colo., Ju
- Unknown outlet
- Unknown outlet